tarextumab

1 stories · following the connections

Business

OncoMed Pharmaceuticals Completes Enrollment of Phase 2 PINNACLE Clinical Trial of Tarextumab in Small Cell Lung Cancer

By Nasdaq OMXAug 30, 2016, 12:00 PM UTC